View ICR - OIRA Conclusion



0910-0701 201804-0910-004
Historical Active 201412-0910-017
HHS/FDA CDER
Guidance for Industry; Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic
Extension without change of a currently approved collection   No
Regular
Approved without change 05/17/2018
04/12/2018
  Inventory as of this Action Requested Previously Approved
05/31/2021 36 Months From Approved 05/31/2018
6,500 0 6,500
262,000 0 262,000
0 0 0